SLSN Solesence
Solesence earnings company data as of 4:48 AM ET 10/23
History
2 periods, newest first. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 10 Nov | EPS | — | — | — |
| Rev | — | — | — | ||
| FY2026 Q2 | 19 Aug | EPS | — | -0.01 | — |
| Rev | — | $15.3M | — |
Insider trades
Open-market buys and sales by SLSN's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $68K bought by 1 insider
- None no sales outside a trading plan
- None no planned (10b5-1) sales
-
R Janet Whitmore DirectorBuy$4,787 2,500 shares at $1.91 +0.1% to stakeTraded Dec 24, 2025 Filed Dec 30, 2025
-
R Janet Whitmore DirectorBuy$63K 35,056 shares at $1.80 +1.7% to stakeTraded Nov 14–19 Filed Dec 11, 2025
SEC filings
Recent issuer filings from EDGAR, 25 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 8-K | 1.01,9.01 | Filing Doc | |
| 8-K | 3.01,9.01 | Filing Doc | |
| 8-K | 4.02,9.01 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | QUARTERLY REPORT | Filing Doc | |
| 8-K | 1.01,9.01 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | QUARTERLY REPORT | Filing Doc | |
| 8-K | 5.02,9.01 | Filing Doc | |
| 10-K/A | AMENDMENT TO FORM 10-K | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-K | ANNUAL REPORT | Filing Doc | |
| 8-K | 5.02,9.01 | Filing Doc | |
| 8-K | 1.01,5.02,9.01 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | QUARTERLY REPORT | Filing Doc | |
| 8-K | 1.01,9.01 | Filing Doc | |
| 8-K | 1.01,5.02,9.01 | Filing Doc | |
| 8-K | 5.07 | Filing Doc | |
| 10-Q | QUARTERLY REPORT | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| DEF 14A | DEFINITIVE PROXY STATEMENT | Filing Doc | |
| 8-K | 5.03,9.01 | Filing Doc | |
| SCHEDULE 13D/A | — | Filing Doc | |
| 8-K | 1.01,7.01,9.01 | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.